Hyperprolactinaemia caused by antipsychotic drugs: A new application for prolactin assays

Annals of Clinical Biochemistry

Volumn 47, Issue 4, 2010, Pages 287-289

  Ellis, Andrew ^a   Fahie Wilson, Michael ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b Chiltern House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PROLACTIN;

CLINICAL ASSESSMENT; EDITORIAL; HORMONE DETERMINATION; HUMAN; HYPERPROLACTINEMIA; IMMUNOASSAY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL;

ANTIPSYCHOTIC AGENTS; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; PROLACTIN; REFERENCE VALUES; SPECIMEN HANDLING; TIME FACTORS;

EID: 77954422709     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.201009     Document Type: Editorial

References (11)

1. Bushe CJ, Bradley A, Pendlebury J. A review of hyperprolactinaemia and serious mental illness: are there implications for clinical biochemistry? Ann Clin Biochem 2010;47:292-300
2. Wieck A, Haddad P. Hyperprolactinaemia caused by antipsychotic drugs. BMJ 2002;324:250-2
3. Peveler RC, Branford D, Citrome L, et al. Antipsychotics and hyperprolactinamia: clinical recommendations. J Psychopharmacol 2008;22(Suppl.):98-103
4. Jassam NF, Paterson A, Lippiatt C, Barth JH. Macroprolactin on the Advia Centaur: experience with 409 patients over a three-year period. Ann Clin Biochem 2009;46:501-4
5. Beltran L, Fahie-Wilson M, McKenna TJ, Kavanagh L, Smith TP. Reference intervals for serum total prolactin and monomeric prolactin determined by precipitation with polyethylene glycol: evaluation and validation on major immunoassay platforms. Clin Chem 2008;54:1673-81
6. Sturgeon CM, Ellis AR, Al-Sadie R. UK NEQAS for Peptide Hormones and Related Substances - Annual Review 2007, Department of Clinical Biochemistry, Royal Infirmary, Edinburgh, UK, Appendix page A10-17
7. Jeffcoate SL, Bacon RRA, Beastall GH, Diver MJ, Franks S, Seth J. Assays for prolactin: guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem 1986;23:638-51
8. Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal programme. Clin Chem Lab Med 2004;42:710-4
9. Turrone P, Kapur S, Seeman MV, Flint AS. Elevation of prolactin levels by atypical antipsychotics. Am J Psychiatry 2002;159:133-5
10. Suliman AM, Smith TP, Gibney J, McKenna TJ. Frequent misdiagnosis & mismanagement of hyperprolactinaemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinaemia. Clin Chem 2003;49:1504-9 (Pubitemid 37011739)
11. Fahie-Wilson John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005;42:175-92